Endoscopy 2023; 55(S 02): S22
DOI: 10.1055/s-0043-1765042
Abstracts | ESGE Days 2023
Oral presentation
ERCP, EUS, and the pancreas 20/04/2023, 10:00 – 11:00 Liffey Meeting Room 1

Long-term efficacy of a modified non-flared fully covered metal stent for benign main pancreatic duct strictures: results of a 6-year follow-up study

J. H. Myeong
1   Soonchunhyang University Bucheon Hospital, Bucheon, Korea, Republic of
,
J. H. Moon
1   Soonchunhyang University Bucheon Hospital, Bucheon, Korea, Republic of
,
Y. N. Lee
1   Soonchunhyang University Bucheon Hospital, Bucheon, Korea, Republic of
,
I. S. Shin
1   Soonchunhyang University Bucheon Hospital, Bucheon, Korea, Republic of
,
J. K. Yang
2   Soonchunhyang University Cheonan Hospital, Cheonan, Korea, Republic of
,
T. H. Lee
2   Soonchunhyang University Cheonan Hospital, Cheonan, Korea, Republic of
,
S. W. Cha
3   Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of
,
Y. D. Cho
3   Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of
,
S. H. Park
2   Soonchunhyang University Cheonan Hospital, Cheonan, Korea, Republic of
› Author Affiliations
 
 

    Aims Despite fully covered self-expandable metal stents (FCSEMSs) can be effective for the treatment of main pancreatic duct (MPD) strictures associated with chronic pancreatitis, relevant long-term results are rarely reported. We evaluated the long-term efficacy of the modified non-flared FCSEMS (M-FCSEMS) in patients with benign MPD strictures due to chronic pancreatitis.

    Methods We reviewed our database for patients who underwent complete resolution of MPD stricture after placement of M-FCSEMS. The M-FCSEMS was placed intraductally or transpapillary according to the location and length of the stricture. Stent removal was performed at 3 months after placement. The primary outcome was the recurrence of MPD stricture that requires re-intervention during the follow-up period.

    Results Endoscopic placement of M-FCSEMSs was technically successful for all 25 patients, and achieved the resolution of stricture. Intraductal placement was performed in 11 patients (44.0%). Intended stent removal was successful in all patients. Re-intervention for the management of MPD stricture recurrence was performed in 12.0% (3/25) of patients during 76.9 months of median duration of follow-up (interquartile range [IQR], 52.5 – 93.8 months). No FCSEMS-related de novo stricture was observed.

    Conclusions These findings from long-term follow-up results suggest that M-FCSEMS shows long-term efficacy for stricture resolution without de novo stricture in patients with benign MPD stricture.


    #

    Conflicts of interest

    Authors do not have any conflict of interest to disclose.

    Publication History

    Article published online:
    14 April 2023

    © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany